UK Companies House feature
FOCUS PHARMACEUTICALS LIMITED
Profile
- Company number
- 04522142
- Status
- Active
- Incorporation
- 2002-08-30
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of operations as they fall due. In assessing the ability of the Company to continue as a going concern, the directors have taken account of the cumulative profits of £10,318,894, and the Company's net current assets and net asset position of £10,674,034 as at 31 December 2024. The Company's intermediate holding company, APHL has provided the Company with a letter of support indicating its intention to provide the financial support required for a period of at least 12 months from the date these financial statements are approved.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TMF CORPORATE ADMINISTRATION SERVICES LIMITED | Corporate Secretary | 2022-03-16 | — | — |
| IDRIS, Amaar Fainan | Director | 2025-02-06 | May 1984 | British |
| STICKLER, Andreas | Director | 2022-01-21 | Feb 1971 | German |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GRETHE, Richard Paul | Secretary | 2004-12-01 | 2014-10-01 |
| LEAVER, Linda | Secretary | 2002-10-28 | 2003-10-01 |
| MAGINLEY, Bronson Raymond | Secretary | 2003-10-01 | 2004-12-01 |
| SULLY, Robert | Secretary | 2018-10-01 | 2022-03-16 |
| SULLY, Robert James | Secretary | 2014-10-01 | 2016-12-31 |
| WILLIAMS, David Richard | Secretary | 2016-12-31 | 2018-10-01 |
| FORM 10 SECRETARIES FD LTD | Corporate Nominee Secretary | 2002-08-30 | 2002-09-17 |
| AHMAD, Adeel | Director | 2016-01-08 | 2022-01-31 |
| BEIGHTON, John | Director | 2014-10-01 | 2016-12-31 |
| BROWN, Roland Alexander | Director | 2002-10-28 | 2014-10-01 |
| CRESSWELL, Mark | Director | 2002-10-28 | 2014-10-01 |
| DUNCAN, Graeme Neville | Director | 2018-11-30 | 2022-01-12 |
| DUNCAN, Graeme Neville | Director | 2016-12-31 | 2018-03-08 |
| GRETHE, Richard Paul | Director | 2004-12-01 | 2014-10-01 |
| KAMATH, Vikram Laxman | Director | 2016-12-31 | 2025-02-06 |
| LEAVER, Andrew Derrick | Director | 2002-10-28 | 2007-10-19 |
| MAGINLEY, Bronson Raymond | Director | 2002-10-28 | 2014-10-01 |
| VAN TIGGELEN, Antonie Pieter | Director | 2014-10-01 | 2016-01-08 |
| FORM 10 DIRECTORS FD LTD | Corporate Nominee Director | 2002-08-30 | 2002-09-17 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mercury Pharma Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-16 | Active |
| Focus Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-01 | Ceased 2021-12-16 |
| The Blackstone Group Inc. | Corporate entity | Shares 25–50%, Voting 25–50% | 2020-03-27 | Ceased 2021-06-01 |
| Focus Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-10 | Ceased 2020-03-27 |
Filing timeline
Last 20 of 156 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-08-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-30 | AA | accounts | accounts with accounts type full |
| 2025-02-19 | AP01 | officers | appoint person director company with name date |
| 2025-02-19 | TM01 | officers | termination director company with name termination date |
| 2024-09-02 | AA | accounts | accounts with accounts type full |
| 2024-08-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-16 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-08-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-09 | CH01 | officers | change person director company with change date |
| 2023-08-09 | CH01 | officers | change person director company with change date |
| 2023-08-09 | CH01 | officers | change person director company with change date |
| 2023-08-03 | AA | accounts | accounts with accounts type full |
| 2023-08-01 | AD01 | address | change registered office address company with date old address new address |
| 2023-07-28 | CH04 | officers | change corporate secretary company with change date |
| 2022-09-30 | AA | accounts | accounts with accounts type full |
| 2022-08-02 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-03-28 | AP04 | officers | appoint corporate secretary company with name date |
| 2022-03-28 | TM02 | officers | termination secretary company with name termination date |
| 2022-02-02 | AP01 | officers | appoint person director company with name date |
| 2022-02-01 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory